Cancer, Advanced Recruiting Phase 1 Trials for Bevacizumab (DB00112)

Also known as: Advanced Cancer / Cancer / Neoplasm malignant / Malignant neoplasm NOS / Cancer NOS / Malignant tumor / Malignant tumour / Cancer (NOS) / Malignant neoplasm without specification of site

IndicationStatusPhase
DBCOND0041606 (Cancer, Advanced)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03307785Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042Treatment